SMS Pharmaceuticals announced that the Board of Directors of the Company at its meeting held on 29 May 2024, inter alia, have recommended the final dividend of Rs 0.4 per equity Share (i.e. 40%) , subject to the approval of the shareholders.Powered by Capital Market - Live News

Net profit of SMS Pharmaceuticals rose 177.81% to Rs 17.28 crore in the quarter ended March 2024 as against Rs 6.22 crore during the previous quarter ended March 2023. Sales rose 64.49% to Rs 245.80 crore in the quarter ended March 2024 as against Rs 149.43 crore during the previous quarter ended March 2023.For the full year,net profit reported to Rs 49.83 crore in the year ended March 2024 as against net loss of Rs 7.06 crore during the previous year ended March 2023. Sales rose 35.86% to Rs 709.26 crore in the year ended March 2024 as against Rs 522.05 crore during the previous year ended March 2023. ParticularsQuarter EndedYear Ended�Mar. 2024Mar. 2023% Var.Mar. 2024Mar. 2023% Var. Sales245.80149.43 64 709.26522.05 36 OPM %13.6715.55 -16.4410.44 - PBDT29.6518.61 59 97.6237.47 161 PBT21.7410.63 105 66.115.35 1136 NP17.286.22 178 49.83-7.06 LP Powered by Capital Market - Live News

SMS Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 29 May 2024Powered by Capital Market - Live News

SMS Pharmaceuticals announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 6 March 2024 .Powered by Capital Market - Live News

Net profit of SMS Pharmaceuticals rose 205.32% to Rs 11.48 crore in the quarter ended December 2023 as against Rs 3.76 crore during the previous quarter ended December 2022. Sales rose 8.52% to Rs 161.48 crore in the quarter ended December 2023 as against Rs 148.80 crore during the previous quarter ended December 2022. ParticularsQuarter Ended�Dec. 2023Dec. 2022% Var. Sales161.48148.80 9 OPM %17.9612.45 - PBDT24.5414.79 66 PBT16.536.67 148 NP11.483.76 205 Powered by Capital Market - Live News